Adoptive cell transfer: New technique could make cell-based immune therapies for cancer safer, more effective
A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development ...
Dec 16, 2012